Infected Joint Prosthesis in a 56-Year-Old with Psoriasis


Low risk

Breast biopsy or excision

Bronchoscopy

Cystoscopy

Dermatologic procedure

Endoscopy

Hysteroscopy

Ophthalmologic operation

Outpatient procedure

Intermediate risk

Abdominal or thoracic operation (uncomplicated)

Carotid endarterectomy

Head and neck procedure (uncomplicated)

Orthopedic procedure

Prostate operation

Urologic procedure

High risk

Aortic or main vascular operation

Cardiac surgery

Emergency procedure

Extended surgery time (>4 h)

Major thoracic surgery

Peripheral arterial vascular operation




Table 13.2
Suggested preoperative discontinuation time and half-lives of immunomodulatory therapy for psoriasis or psoriatic arthritis (reproduced from Choi et al. 2016)






























Immunomodulatory medication

Half-life

Suggested preoperative discontinuation period

Adalimumab

14–19 days

8–11 weeks

Certolizumab pegol

14 days

8 weeks

Cyclosporine

8 h

1.5 days

Etanercept

3–5 days

2–3 weeks

Golimumab

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Aug 20, 2017 | Posted by in Dermatology | Comments Off on Infected Joint Prosthesis in a 56-Year-Old with Psoriasis

Full access? Get Clinical Tree

Get Clinical Tree app for offline access